Sorry for the delay and writing on the run. On Operon’s website there was an article from March(last year) talking about them getting funding to concentrate on ramping up Covid product production.
I don’t have it handy, but I’ve also read an article about Operon producing 1m tests per month for a customer this year. Also I’ve heard from the company and while they haven’t given specific numbers, they’ve said that Operon are about to triple their production capacity which will be available to their customers which includes AnteoTech.
Hope that helps.
Ann: Test Platform and COVID-19 Test receive CE Mark approval, page-239
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $67.22M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1838 | 2.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.5¢ | 2160397 | 2 |
View Market Depth
| Last trade - 16.12pm 11/11/2024 (20 minute delay) ? |
| ADO (ASX) Chart |
Day chart unavailable